OPERATIONAL CHALLENGES FOR IMPLEMENTING THE "TORONTO PROTOCOL", GLECAPREVIR/PIBRENTASVIR plus EZETIMIBE, FOR SOLID ORGAN TRANSPLANTATION FROM HCV NAT plus DONORS TO HCV-UNINFECTED RECIPIENTS

GASTROENTEROLOGY(2023)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要